Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1988 Jan;71(1):164–170.

Immunohistochemical demonstration of migration inhibitory factor (MIF) in experimental allergic contact dermatitis.

U Malorny 1, J Knop 1, G Burmeister 1, C Sorg 1
PMCID: PMC1541650  PMID: 3280179

Abstract

The kinetics of appearance of MIF+ cells was investigated in experimental contact dermatitis using a monoclonal antibody (7D10) against murine MIF which was reacted with cryostat sections of tissues and detected by the indirect immunoperoxidase test. Four groups of BALB/c mice were investigated: (1) sensitized with 2,4-dinitrofluorobenzene (DNFB); (2) unsensitized controls; (3) tolerized; (4) unsensitized. A challenge dose of DNFB was applied to the ear of animals of groups 1-3 and of croton oil to those of group 4. Three phases could be distinguished in group 1: (a) an initial vascular and exudative reaction; (b) an early cellular phase; and (c) a late cellular phase. At zero time rarely any T lymphocytes (Lyt 1+; Lyt 2+) were seen in all four groups. Within less than 30 min venous endothelial cells became strongly MIF+. This was followed by an influx of monocytes/macrophages reaching a maximum of 72 h in group 1 and a slight peak at 12 h in groups 2 and 3. At 16-24 h in all groups the endothelial reaction weakened while many 7D10+ macrophages appeared in group 1. By double-labelling it was shown that lymphocytes were 7D10-. The influx of lymphocytes, part of which carried the T cell receptor, began at 12 h, reaching a maximum at 72 h in group 1. In groups 2 and 3 only a weak lymphocytic infiltrate developed which declined at 24 h. Group 4 developed an inflammatory reaction after the initial phase with similar kinetics as in group 1. The data suggest that an immune inflammatory reaction is preceded by a nonspecific reaction of the vascular endothelium and the mononuclear phagocytic system and that MIF is playing a central role in these events.

Full text

PDF
164

Images in this article

166Fig. 1
on p.166
166Fig. 2
on p.166
167Fig. 3
on p.167
167Fig. 4
on p.167

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bloom B. R., Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science. 1966 Jul 1;153(3731):80–82. doi: 10.1126/science.153.3731.80. [DOI] [PubMed] [Google Scholar]
  2. Burmeister G., Tarcsay L., Sorg C. Generation and characterization of a monoclonal antibody (1C5) to human migration inhibitory factor (MIF). Immunobiology. 1986 Jul;171(4-5):461–474. doi: 10.1016/S0171-2985(86)80077-8. [DOI] [PubMed] [Google Scholar]
  3. Farr A. G., Anderson S. K., Marrack P., Kappler J. Expression of antigen-specific, major histocompatibility complex-restricted receptors by cortical and medullary thymocytes in situ. Cell. 1985 Dec;43(2 Pt 1):543–550. doi: 10.1016/0092-8674(85)90183-7. [DOI] [PubMed] [Google Scholar]
  4. Kaufmann S. H., Hug E., De Libero G. Listeria monocytogenes-reactive T lymphocyte clones with cytolytic activity against infected target cells. J Exp Med. 1986 Jul 1;164(1):363–368. doi: 10.1084/jem.164.1.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Knop J., Malorny U., Macher E. Selective induction of delayed hypersensitivity T-effector and T-suppressor lymphocytes in vitro by haptenized bone marrow-derived macrophages. Cell Immunol. 1984 Oct 15;88(2):411–420. doi: 10.1016/0008-8749(84)90174-6. [DOI] [PubMed] [Google Scholar]
  6. Knop J., Malorny U., Michels E., Sorg C. Selection of the delayed hypersensitivity T effector and T suppressor cell response by antigen-presenting macrophages. Immunobiology. 1984 Dec;168(3-5):246–259. doi: 10.1016/S0171-2985(84)80114-X. [DOI] [PubMed] [Google Scholar]
  7. Malorny U., Michels E., Sorg C. A monoclonal antibody against an antigen present on mouse macrophages and absent from monocytes. Cell Tissue Res. 1986;243(2):421–428. doi: 10.1007/BF00251059. [DOI] [PubMed] [Google Scholar]
  8. Michels E., Stenzinger W., Sorg C. Functional characteristics of murine macrophages responding to migration inhibitory factors. Eur J Immunol. 1984 Oct;14(10):902–905. doi: 10.1002/eji.1830141008. [DOI] [PubMed] [Google Scholar]
  9. Neumann C., Schlegel R., Steckel F., Sorg C. Detection of macrophage migration inhibitory factor by monoclonal antibody in Sézary syndrome. J Invest Dermatol. 1987 Jun;88(6):670–674. doi: 10.1111/1523-1747.ep12470326. [DOI] [PubMed] [Google Scholar]
  10. Platt J. L., Grant B. W., Eddy A. A., Michael A. F. Immune cell populations in cutaneous delayed-type hypersensitivity. J Exp Med. 1983 Oct 1;158(4):1227–1242. doi: 10.1084/jem.158.4.1227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Poulter L. W., Seymour G. J., Duke O., Janossy G., Panayi G. Immunohistological analysis of delayed-type hypersensitivity in man. Cell Immunol. 1982 Dec;74(2):358–369. doi: 10.1016/0008-8749(82)90036-3. [DOI] [PubMed] [Google Scholar]
  12. Reitamo S., Tolvanen E., Konttinen Y. T., Käyhkö K., Förström L., Salo O. P. Allergic and toxic contact dermatitis: inflammatory cell subtypes in epicutaneous test reactions. Br J Dermatol. 1981 Nov;105(5):521–527. doi: 10.1111/j.1365-2133.1981.tb00795.x. [DOI] [PubMed] [Google Scholar]
  13. Scheynius A., Fischer T., Forsum U., Klareskog L. Phenotypic characterization in situ of inflammatory cells in allergic and irritant contact dermatitis in man. Clin Exp Immunol. 1984 Jan;55(1):81–90. [PMC free article] [PubMed] [Google Scholar]
  14. Scheynius A., Klareskog L., Forsum U. In situ identification of T lymphocyte subsets and HLA-DR expressing cells in the human skin tuberculin reaction. Clin Exp Immunol. 1982 Aug;49(2):325–330. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES